Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inverse association between breast cancer incidence and degree of visual impairment in Finland.

Literature DB >> 10424751

Inverse association between breast cancer incidence and degree of visual impairment in Finland.

P K Verkasalo¹, E Pukkala, R G Stevens, M Ojamo, S L Rudanko.

Abstract

A total of 10935 women with visual impairment were identified from the Finnish Register of Visual Impairment and followed up for cancer through the Finnish Cancer Registry for years 1983-1996. Breast cancer risk decreased by degree of visual impairment (P for trend 0.04) which suggests a dose-response relationship between visible light and breast cancer risk.

Entities: Disease Species

Mesh：

Substances：
Melatonin

Year: 1999 PMID： 10424751 PMCID： PMC2363081 DOI： 10.1038/sj.bjc.6690544

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

8 in total

Review 1. Melatonin in humans.

Authors: A Brzezinski
Journal: N Engl J Med Date: 1997-01-16 Impact factor: 91.245

2. Profound bilateral blindness and the incidence of breast cancer.

Authors: R A Hahn
Journal: Epidemiology Date: 1991-05 Impact factor: 4.822

Review 3. Electric power use and breast cancer: a hypothesis.

Authors: R G Stevens
Journal: Am J Epidemiol Date: 1987-04 Impact factor: 4.897

4. Visual impairment and cancer: a population-based cohort study in Finland.

Authors: E Pukkala; P K Verkasalo; M Ojamo; S L Rudanko
Journal: Cancer Causes Control Date: 1999-02 Impact factor: 2.506

5. Reduced cancer incidence among the blind.

Authors: M Feychting; B Osterlund; A Ahlbom
Journal: Epidemiology Date: 1998-09 Impact factor: 4.822

Review 6. Melatonin: receptor-mediated events that may affect breast and other steroid hormone-dependent cancers.

Authors: W S Baldwin; J C Barrett
Journal: Mol Carcinog Date: 1998-03 Impact factor: 4.784

7. Suppression of melatonin secretion in some blind patients by exposure to bright light.

Authors: C A Czeisler; T L Shanahan; E B Klerman; H Martens; D J Brotman; J S Emens; T Klein; J F Rizzo
Journal: N Engl J Med Date: 1995-01-05 Impact factor: 91.245

8. Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo.

Authors: D E Blask; D B Pelletier; S M Hill; A Lemus-Wilson; D S Grosso; S T Wilson; M E Wise
Journal: J Cancer Res Clin Oncol Date: 1991 Impact factor: 4.553

8 in total

14 in total

Review 1. Light, timing of biological rhythms, and chronodisruption in man.

Authors: Thomas C Erren; Russel J Reiter; Claus Piekarski
Journal: Naturwissenschaften Date: 2003-10-14

2. Does "clock" matter in prostate cancer?

Authors: Yong Zhu; Tongzhang Zheng; Richard G Stevens; Yawei Zhang; Peter Boyle
Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-01 Impact factor: 4.254

3. Breast cancer risk among Finnish cabin attendants: a nested case-control study.

Authors: K Kojo; E Pukkala; A Auvinen
Journal: Occup Environ Med Date: 2005-07 Impact factor: 4.402

Review 4. Artificial light at night: melatonin as a mediator between the environment and epigenome.

Authors: Abraham Haim; Abed E Zubidat
Journal: Philos Trans R Soc Lond B Biol Sci Date: 2015-05-05 Impact factor: 6.237

5. Extended exposure to dietary melatonin reduces tumor number and size in aged male mice.

Authors: Edward H Sharman; Kaizhi G Sharman; Stephen C Bondy
Journal: Exp Gerontol Date: 2010-09-16 Impact factor: 4.032

Review 6. Shift work and cancer: the evidence and the challenge.

Authors: Thomas C Erren; Puran Falaturi; Peter Morfeld; Peter Knauth; Russel J Reiter; Claus Piekarski
Journal: Dtsch Arztebl Int Date: 2010-09-24 Impact factor: 5.594

Review 7. Protective role of melatonin in breast cancer: what we can learn from women with blindness.

Authors: Chris Minella; Pierre Coliat; Shanti Amé; Karl Neuberger; Alexandre Stora; Carole Mathelin; Nathalie Reix
Journal: Cancer Causes Control Date: 2021-11-27 Impact factor: 2.506

8. Light-at-night, circadian disruption and breast cancer: assessment of existing evidence.

Authors: Richard G Stevens
Journal: Int J Epidemiol Date: 2009-04-20 Impact factor: 7.196

Review 9. The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis.

Authors: Lonnele J Ball; Oxana Palesh; Lance J Kriegsfeld
Journal: Endocr Rev Date: 2016-07-26 Impact factor: 19.871

10. Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study.

Authors: M Kakizaki; S Kuriyama; T Sone; K Ohmori-Matsuda; A Hozawa; N Nakaya; S Fukudo; I Tsuji
Journal: Br J Cancer Date: 2008-09-23 Impact factor: 7.640